Nusano News
Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development
Image above: Starget Pharma, stargetpharma.comVALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of...
Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes
Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial...
Nusano Named to Insights Care 5 Most Trusted Radiopharmaceutical Companies to Watch
September 2024 – Insights Care recently interviewed Nusano CEO Chris Lowe for its "5 Most Trusted Radiopharmaceutical...
Nusano Featured in Biosphere Magazine
Nusano is featured in the 2024 edition of Biosphere magazine entitled "Profiles in Innovation." Published by BioUtah,...
Industry News
Welsh Government seeks to create ‘global centre of excellence in nuclear medicine’
The Welsh Government is working to secure a stable supply of medical radioisotopes for United Kingdom citizens for decades to come.
Global radioisotope shortage hits patients in Pennsylvania
Patients in Pennsylvania are notified that some imaging procedures may need to be delayed or rescheduled due to global shortages in medical radioisotopes.
Toronto Star: Sudden shortage of vital isotope hitting Canadian hospitals
Nov. 10, 2022 – The unexpected shut down of a nuclear reactor in Belgium is creating issues for patients in Canada...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates